KYORIN PHARMACEUTICAL CO., LTD.

Press Releases KYORIN Pharmaceutical Co., Ltd.

Equities

4569

JP3247090008

Market Closed - Japan Exchange Other stock markets 11:30:00 14/06/2024 am IST			5-day change	1st Jan Change
1,683 ^JPY	+0.12%		+1.57%	-5.45%

2023	ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan	MT
2021	KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KYORIN Pharmaceutical : Supplementary Information (May 11, 2024)	13/05	PU
KYORIN Pharmaceutical : Integrated Report 2023 Batch download (Single Page) [ 10.6MB	29/23/29	PU
KYORIN Pharmaceutical : Summary of Consolidated Financial Results (August 2, 2023) [ 202 KB	02/23/02	PU
KYORIN Pharmaceutical : Supplementary Information (August 2, 2023) [ 530 KB	02/23/02	PU
ATyr Pharma Announces Achievement of Development Milestone by Partner Kyorin Pharmaceutical, Co., Ltd	07/23/07	AQ
KYORIN : 2Q FY2022 presentation for financial results	10/22/10	PU
KYORIN : FY2020 presentation for financial results	12/21/12	PU
Otonomy : Reports First Quarter 2021 Financial Results and Provides Corporate Update	12/21/12	AQ
Otonomy : Reports Third Quarter 2020 Financial Results and Provides Corporate Update	05/20/05	AQ
ATYR PHARMA : ANNOUNCES PARTNER KYORIN PHARMACEUTICAL CO., LTD. DOSES FIRST SUBJECTS IN PHASE 1 TRIAL OF ATYR1923 IN JAPAN	16/20/16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer